Detalhe da pesquisa
1.
Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review.
Ther Drug Monit;
44(1): 86-102, 2022 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34772891
2.
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study.
Clin Infect Dis;
72(8): 1369-1378, 2021 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32150603
3.
Pharmacokinetic/Pharmacodynamic Dosage Individualization of Cefepime in Critically Ill Patients: A Case Study.
Ther Drug Monit;
43(4): 451-454, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33883521
4.
Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize A Priori Pharmacokinetic/Pharmacodynamic Target Attainments in Individual Patients.
Antimicrob Agents Chemother;
63(11)2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31481443
5.
Lung Pharmacokinetics of Tobramycin by Intravenous and Nebulized Dosing in a Mechanically Ventilated Healthy Ovine Model.
Anesthesiology;
131(2): 344-355, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31107274
6.
Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
Anaesth Crit Care Pain Med;
39(1): 87-109, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31513935
7.
Determinants of amikacin first peak concentration in critically ill patients.
Fundam Clin Pharmacol;
32(6): 669-677, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29660162